An engineered protein that binds to the envelope of HIV viruses protects monkeys against infection with a simian–human virus that causes AIDS. This gene-therapy approach might provide an alternative to elusive HIV vaccines. See Letter p.87
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Rerks-Ngarm, S. et al. N. Engl. J. Med. 361, 2209–2220 (2009).
Gardner, M. R. et al. Nature 519, 87–91 (2015).
Dalgleish, A. G. et al. Nature 312, 763–767 (1984).
Klatzmann, D. et al. Nature 312, 767–768 (1984).
Farzan, M. et al. Cell 96, 667–676 (1999).
Hansen, S. G. et al. Nature 502, 100–104 (2013).
Johnson, P. R. et al. Nature Med. 15, 901–906 (2009).
Hoxie, J. A. Annu. Rev. Med. 61, 135–152 (2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haigwood, N. Tied down by its own receptor. Nature 519, 36–37 (2015). https://doi.org/10.1038/nature14205
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14205
